These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 31627290)
1. The SOD Mimic MnTnHex-2-PyP Costa JG; Saraiva N; Batinic-Haberle I; Castro M; Oliveira NG; Fernandes AS Antioxidants (Basel); 2019 Oct; 8(10):. PubMed ID: 31627290 [TBL] [Abstract][Full Text] [Related]
2. The manganese(III) porphyrin MnTnHex-2-PyP Flórido A; Saraiva N; Cerqueira S; Almeida N; Parsons M; Batinic-Haberle I; Miranda JP; Costa JG; Carrara G; Castro M; Oliveira NG; Fernandes AS Redox Biol; 2019 Jan; 20():367-378. PubMed ID: 30408752 [TBL] [Abstract][Full Text] [Related]
3. Mechanism of the Antitumor and Radiosensitizing Effects of a Manganese Porphyrin, MnHex-2-PyP. Shin SW; Choi C; Lee GH; Son A; Kim SH; Park HC; Batinic-Haberle I; Park W Antioxid Redox Signal; 2017 Nov; 27(14):1067-1082. PubMed ID: 28358581 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive pharmacokinetic studies and oral bioavailability of two Mn porphyrin-based SOD mimics, MnTE-2-PyP5+ and MnTnHex-2-PyP5+. Weitner T; Kos I; Sheng H; Tovmasyan A; Reboucas JS; Fan P; Warner DS; Vujaskovic Z; Batinic-Haberle I; Spasojevic I Free Radic Biol Med; 2013 May; 58():73-80. PubMed ID: 23328731 [TBL] [Abstract][Full Text] [Related]
5. Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics. Batinic-Haberle I; Rajic Z; Tovmasyan A; Reboucas JS; Ye X; Leong KW; Dewhirst MW; Vujaskovic Z; Benov L; Spasojevic I Free Radic Biol Med; 2011 Sep; 51(5):1035-53. PubMed ID: 21616142 [TBL] [Abstract][Full Text] [Related]
6. Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors. Keir ST; Dewhirst MW; Kirkpatrick JP; Bigner DD; Batinic-Haberle I Anticancer Agents Med Chem; 2011 Feb; 11(2):202-12. PubMed ID: 21291403 [TBL] [Abstract][Full Text] [Related]
7. MnTnHex-2-PyP Soares RB; Manguinhas R; Costa JG; Saraiva N; Gil N; Rosell R; Camões SP; Batinic-Haberle I; Spasojevic I; Castro M; Miranda JP; Amaro F; Pinto J; Fernandes AS; Guedes de Pinho P; Oliveira NG Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36358570 [TBL] [Abstract][Full Text] [Related]
8. Fe Porphyrin-Based SOD Mimic and Redox-Active Compound, (OH)FeTnHex-2-PyP Li L; Tovmasyan A; Sheng H; Xu B; Sampaio RS; Reboucas JS; Warner DS; Batinic-Haberle I; Spasojevic I Antioxidants (Basel); 2020 Jun; 9(6):. PubMed ID: 32492872 [TBL] [Abstract][Full Text] [Related]
9. Impact of the redox-active MnTnHex-2-PyP Soares RB; Pinto J; Amaro F; Manguinhas R; Gil N; Rosell R; Batinic-Haberle I; Fernandes AS; Oliveira NG; Guedes de Pinho P Biochem Pharmacol; 2024 Sep; 227():116424. PubMed ID: 39004232 [TBL] [Abstract][Full Text] [Related]
10. Manganese porphyrin redox state in endothelial cells: Resonance Raman studies and implications for antioxidant protection towards peroxynitrite. Carballal S; Valez V; Alvarez-Paggi D; Tovmasyan A; Batinic-Haberle I; Ferrer-Sueta G; Murgida DH; Radi R Free Radic Biol Med; 2018 Oct; 126():379-392. PubMed ID: 30144631 [TBL] [Abstract][Full Text] [Related]
11. Manganese Porphyrin-Based SOD Mimetics Produce Polysulfides from Hydrogen Sulfide. Olson KR; Gao Y; Arif F; Patel S; Yuan X; Mannam V; Howard S; Batinic-Haberle I; Fukuto J; Minnion M; Feelisch M; Straub KD Antioxidants (Basel); 2019 Dec; 8(12):. PubMed ID: 31842297 [TBL] [Abstract][Full Text] [Related]
12. Ochratoxin A-induced cytotoxicity, genotoxicity and reactive oxygen species in kidney cells: An integrative approach of complementary endpoints. Costa JG; Saraiva N; Guerreiro PS; Louro H; Silva MJ; Miranda JP; Castro M; Batinic-Haberle I; Fernandes AS; Oliveira NG Food Chem Toxicol; 2016 Jan; 87():65-76. PubMed ID: 26627377 [TBL] [Abstract][Full Text] [Related]
13. Anticancer therapeutic potential of Mn porphyrin/ascorbate system. Tovmasyan A; Sampaio RS; Boss MK; Bueno-Janice JC; Bader BH; Thomas M; Reboucas JS; Orr M; Chandler JD; Go YM; Jones DP; Venkatraman TN; Haberle S; Kyui N; Lascola CD; Dewhirst MW; Spasojevic I; Benov L; Batinic-Haberle I Free Radic Biol Med; 2015 Dec; 89():1231-47. PubMed ID: 26496207 [TBL] [Abstract][Full Text] [Related]
14. MnTM-4-PyP modulates endogenous antioxidant responses and protects primary cortical neurons against oxidative stress. Cheng KY; Guo F; Lu JQ; Cao YZ; Wang TC; Yang Q; Xia Q CNS Neurosci Ther; 2015 May; 21(5):435-45. PubMed ID: 25545542 [TBL] [Abstract][Full Text] [Related]
15. A comprehensive evaluation of catalase-like activity of different classes of redox-active therapeutics. Tovmasyan A; Maia CG; Weitner T; Carballal S; Sampaio RS; Lieb D; Ghazaryan R; Ivanovic-Burmazovic I; Ferrer-Sueta G; Radi R; Reboucas JS; Spasojevic I; Benov L; Batinic-Haberle I Free Radic Biol Med; 2015 Sep; 86():308-21. PubMed ID: 26026699 [TBL] [Abstract][Full Text] [Related]
16. Mn Porphyrin-Based Redox-Active Drugs: Differential Effects as Cancer Therapeutics and Protectors of Normal Tissue Against Oxidative Injury. Batinic-Haberle I; Tovmasyan A; Spasojevic I Antioxid Redox Signal; 2018 Dec; 29(16):1691-1724. PubMed ID: 29926755 [TBL] [Abstract][Full Text] [Related]
17. A Redox-active Mn Porphyrin, MnTnBuOE-2-PyP Chaiswing L; Yarana C; St Clair W; Tovmasyan A; Batinic-Haberle I; Spasojevic I; St Clair D Oxid Med Cell Longev; 2022; 2022():9664636. PubMed ID: 35898616 [TBL] [Abstract][Full Text] [Related]